Does Real-World Evidence of the Economic Burden of Lung Cancer in Greece Exist? A Systematic Review of the Literature.

Curr Oncol · 2025 · PMC11941143 · PMID 40136334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The study found a marginally significant difference in costs based on cancer type, with adenocarcinoma patients incurring higher median costs (EUR 9031) compared to SCC (EUR 6606) and SCLC (EUR 5474) patients.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.